MIRA Pharmaceuticals (MIRA)

What Moves the Stock

1. 01Clinical trial data readouts and FDA milestone announcements (Phase advancement, safety signals, efficacy endpoints)
2. 02Capital raises and dilution events (equity offerings, warrant exercises that expand share count)
3. 03Partnership announcements or licensing deals with larger pharmaceutical companies
4. 04Competitive developments in ketamine-based therapies or alternative CNS disorder treatments
5. 05Cash runway updates and quarterly burn rate disclosures
6. 06No current revenue - pre-commercial stage
7. 07Future potential: Licensing agreements or milestone payments from pharma partners (not yet established)
8. 08Future potential: Product sales post-FDA approval (multiple years away, high uncertainty)

MIRA Chart

My Notes

• momentum/speculative - MIRA attracts high-risk tolerance investors seeking asymmetric payoffs from binary clinical events.
• Rising interest rates negatively impact MIRA through multiple channels: (1) Higher discount rates compress NPV of distant future cash flows…
• Watch on earnings: Quarterly cash balance and burn rate (runway to next financing event), Clinical trial enrollment rates and protocol amendments, FDA correspondence and regulatory milestone achievements.